Actively Recruiting
Clinical Evaluation of With or Without Internal Limiting Membrane Peeling for Idiopathic Epiretinal Membrane Surgery: A Randomized Controlled Trial
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2025-08-27
96
Participants Needed
1
Research Sites
147 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Idiopathic epiretinal membrane (ERM) is an age-related degenerative retinal condition. One of the primary treatment approaches is vitrectomy combined with epiretinal membrane peeling. However, whether to concurrently perform internal limiting membrane (ILM) peeling remains clinically controversial. Therefore, this study aims to compare the efficacy and safety of performing versus omitting ILM peeling during idiopathic ERM surgery.
CONDITIONS
Official Title
Clinical Evaluation of With or Without Internal Limiting Membrane Peeling for Idiopathic Epiretinal Membrane Surgery: A Randomized Controlled Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged >18 years presenting to our hospital within the study period.
- Patients diagnosed with idiopathic epiretinal membrane (ERM) based on examination.
- Patients with best-corrected visual acuity (BCVA) �3C= 0.6 or the presence of metamorphopsia.
You will not qualify if you...
- Patients with secondary ERM identified during preoperative evaluation (e.g., secondary to retinal vein occlusion).
- Patients with concomitant ocular diseases affecting the macula, such as macular degeneration, macular schisis, or macular atrophy.
- Patients with a history of ocular trauma or previous ocular surgery (except for cataract surgery).
- Patients with severe systemic diseases contraindicated for surgery.
- Patients with poor compliance or concomitant psychiatric disorders.
- Patients who participated in other clinical trials during the follow-up period or who were lost to follow-up.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Eye Center of the Second Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China, 310058
Actively Recruiting
Research Team
Y
Yueyang Zhong, MD.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here